摘要
天冬氨酸蛋白酶、半胱氨酸蛋白酶和氨肽酶是与人血红蛋白降解及红细胞浸润与破裂过程息息相关的恶性疟原虫蛋白酶。由于抗疟药物的耐药性和寄生虫的自然选择的,我们必须寻求新的作用靶点以使药物达到治疗疟疾的目的。本文总结了蛋白酶和血红蛋白降解抑制剂的研究进展。此外,本文还概括了in silico 生物学预测抗疟药物的靶点、平衡选择和药物-蛋白质相互作用等内容。
关键词: 血红蛋白降解,天冬氨酸蛋白酶,半胱氨酸蛋白酶,药物靶点,疟疾,多态性。
图形摘要
Current Drug Targets
Title:Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets
Volume: 16 Issue: 10
Author(s): Tabish Qidwai
Affiliation:
关键词: 血红蛋白降解,天冬氨酸蛋白酶,半胱氨酸蛋白酶,药物靶点,疟疾,多态性。
摘要: Plasmepsins, falcipains and aminopeptidases are Plasmodium falciparum proteases involved in human host hemoglobin degradation and other processes like erythrocyte invasion and rupture. Antimalarial drug resistance and natural selection in parasite are important reasons that create the urgent need of novel targets and lead compounds to overcome the burden of malaria. This report explored progress of the study covering proteases and their inhibitors specific to hemoglobin degradation. Additionally, in silico predicted antimalarial targets, balancing selection and drug-protein interaction are included.
Export Options
About this article
Cite this article as:
Tabish Qidwai , Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets, Current Drug Targets 2015; 16 (10) . https://dx.doi.org/10.2174/1389450116666150304104123
DOI https://dx.doi.org/10.2174/1389450116666150304104123 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Brain Adaptation to Stressful Stimuli: A New Perspective on Potential Therapeutic Approaches Based on BDNF and NMDA Receptors
CNS & Neurological Disorders - Drug Targets Inflammation and Antiangiogenesis in Cancer
Current Medicinal Chemistry ent-Abietane Lactones from Euphorbia
Mini-Reviews in Medicinal Chemistry In Silico Study of Different Signal Peptides for Secretory Production of Interleukin-11 in Escherichia coli
Current Proteomics Differential Splicing, Disease and Drug Targets
Infectious Disorders - Drug Targets Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry Endotoxin, TLR4 Signaling and Vascular Inflammation: Potential Therapeutic Targets in Cardiovascular Disease
Current Pharmaceutical Design Dynamic Role of Macrophage Sub Types on Development of Atherosclerosis and Potential Use of Herbal Immunomodulators as Imminent Therapeutic Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry Changing the Course of Alzheimers Disease: Emerging Disease Modifying Therapies
Current Psychiatry Reviews Matrix Metalloproteinases
Current Medicinal Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Metabolic Syndrome and Vascular Disease in Asia
Cardiovascular & Hematological Disorders-Drug Targets Membrane Interacting Peptides: A Review
Current Protein & Peptide Science Interferon Treatment in Patients with Hypereosinophilia
Current Drug Targets Advanced Management Options for Endometriosis
Current Women`s Health Reviews Adipose Tissue Derived Stem Cells Secretome: Soluble Factors and Their Roles in Regenerative Medicine
Current Stem Cell Research & Therapy Treatment of Nasopharyngeal Carcinoma: Therapeutic Management and Future View of Epstein-Barr Virus-Targeting Treatment
Current Cancer Therapy Reviews The Impact of Physical Activity on Mitigation of Health Care Costs Related to Diabetes Mellitus: Findings from Developed and Developing Settings
Current Diabetes Reviews Colon as Target for Drug Delivery
Current Drug Therapy Diffuse Alveolar Hemorrhage, A Potentially Life-Threatening Manifestation in Systemic Lupus Erythematosus and the Antiphospholipid Syndrome
Current Respiratory Medicine Reviews